Latest Period
n/a
Security Snapshot
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) Institutional Ownership
CUSIP: 457637601
13F Institutional Holders and Ownership History from Q3 2022 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
- Type / Class
- Equity / Common Shares, no par value
- Symbol
- INM on Nasdaq
- Shares outstanding
- 804,525
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- INM - InMed Pharmaceuticals Inc. - Common Shares, no par value is tracked under CUSIP 457637601.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 0 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $0 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Schedule 13D/13G
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 457637601:
Significant Owners of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | $14,885 | 80,372 | YA II PN, Ltd. | 13 Dec 2024 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$5 | 0 | |
| 2024 Q4 | 0 | $0 | -$265,983 | 0 | |
| 2024 Q3 | 1,141,865 | $265,983 | +$152,049 | $0.24 | 12 |
| 2024 Q2 | 440,244 | $116,623 | -$95,797 | $0.27 | 10 |
| 2024 Q1 | 685,852 | $249,191 | -$42,696 | $0.36 | 14 |
| 2023 Q4 | 804,163 | $334,349 | +$315,907 | $0.42 | 13 |
| 2023 Q3 | 26,865 | $18,551 | +$7,235 | $0.69 | 8 |
| 2023 Q2 | 15,650 | $14,412 | -$91,568 | $0.92 | 7 |
| 2023 Q1 | 100,918 | $109,292 | -$123,996 | $1.08 | 12 |
| 2022 Q4 | 115,828 | $234,169 | -$203,650 | $2.00 | 11 |
| 2022 Q3 | 132,993 | $876,125 | +$876,125 | $6.58 | 8 |